Allurion Technologies, Inc. Operating Expenses
Allurion Technologies, Inc. (ALUR) reported Operating Expenses of $4.96 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-15
- Allurion Technologies, Inc. operating expenses for the quarter ending 2026-03-31 was $4.96M, a 56.65% decline year-over-year.
- Allurion Technologies, Inc. operating expenses for the quarter ending 2025-12-31 was $7.90M, a 59.78% decline year-over-year.
- Allurion Technologies, Inc. operating expenses for the quarter ending 2025-09-30 was $10.93M, a 29.24% decline year-over-year.
- Allurion Technologies, Inc. operating expenses for the quarter ending 2025-06-30 was $9.45M, a 48.48% decline year-over-year.
- Allurion Technologies, Inc. operating expenses for fiscal 2025 was $39.73M, a 44.59% decline from fiscal 2024.
- Allurion Technologies, Inc. operating expenses for fiscal 2024 was $71.70M, a 40.53% decline from fiscal 2023.
- Allurion Technologies, Inc. operating expenses for fiscal 2023 was $120.58M, a 45.73% increase from fiscal 2022.
- Allurion Technologies, Inc. operating expenses for fiscal 2022 was $82.74M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-03-31 | $4.96M 10-Q · filed 2026-05-15 | $12.86M derived: sum of 2 quarters · filed 2026-05-15 | $23.80M derived: sum of 3 quarters · filed 2026-05-15 | $33.24M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | $7.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $18.84M derived: sum of 2 quarters · filed 2026-03-30 | $28.29M derived: sum of 3 quarters · filed 2026-03-30 | $39.73M 10-K · filed 2026-03-30 |
| 2025-09-30 | $10.93M 10-Q · filed 2025-11-17 | $20.38M derived: sum of 2 quarters · filed 2025-11-17 | $31.83M 10-Q · filed 2025-11-17 | $51.47M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $9.45M 10-Q · filed 2025-08-19 | $20.89M 10-Q · filed 2025-08-19 | $40.54M derived: sum of 3 quarters · filed 2026-05-15 | $55.99M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | $11.44M 10-Q · filed 2026-05-15 | $31.09M derived: sum of 2 quarters · filed 2026-05-15 | $46.54M derived: sum of 3 quarters · filed 2026-05-15 | $64.88M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $19.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $35.10M derived: sum of 2 quarters · filed 2026-03-30 | $53.44M derived: sum of 3 quarters · filed 2026-03-30 | $71.70M 10-K · filed 2026-03-30 |
| 2024-09-30 | $15.45M 10-Q · filed 2025-11-17 | $33.79M derived: sum of 2 quarters · filed 2025-11-17 | $52.05M 10-Q · filed 2025-11-17 | $84.22M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | $18.34M 10-Q/A · filed 2025-08-28 | $36.59M 10-Q/A · filed 2025-08-28 | $68.76M derived: sum of 3 quarters · filed 2025-08-28 | $108.89M derived: sum of 4 quarters · filed 2025-08-28 |
| 2024-03-31 | $18.26M 10-Q/A · filed 2025-08-28 | $50.42M derived: sum of 2 quarters · filed 2025-08-28 | $90.55M derived: sum of 3 quarters · filed 2025-08-28 | $113.81M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-12-31 | $32.17M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-08-28 | $72.29M derived: sum of 2 quarters · filed 2025-08-28 | $95.55M derived: sum of 3 quarters · filed 2025-08-28 | $120.58M 10-K/A · filed 2025-08-28 |
| 2023-09-30 | $40.12M 10-Q/A · filed 2025-08-28 | $63.38M derived: sum of 2 quarters · filed 2025-08-28 | $88.41M 10-Q/A · filed 2025-08-28 | $113.80M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-06-30 | $23.26M 10-Q/A · filed 2025-08-28 | $48.28M 10-Q/A · filed 2025-08-28 | $73.68M derived: sum of 3 quarters · filed 2025-08-28 | $98.25M derived: sum of 4 quarters · filed 2025-08-28 |
| 2023-03-31 | $25.02M 10-Q/A · filed 2025-08-28 | $50.41M derived: sum of 2 quarters · filed 2025-08-28 | $74.99M derived: sum of 3 quarters · filed 2025-08-28 | $92.04M derived: sum of 4 quarters · filed 2025-08-28 |
| 2022-12-31 | $25.39M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-28 | $49.97M derived: sum of 2 quarters · filed 2025-08-28 | $67.02M derived: sum of 3 quarters · filed 2025-08-28 | $82.74M 10-K/A · filed 2025-08-28 |
| 2022-09-30 | $24.57M 10-Q · filed 2023-11-14 | $41.62M derived: sum of 2 quarters · filed 2023-11-14 | $57.34M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $17.05M 10-Q · filed 2023-10-20 | $32.77M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |